Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry.


Journal

Cardiovascular intervention and therapeutics
ISSN: 1868-4297
Titre abrégé: Cardiovasc Interv Ther
Pays: Japan
ID NLM: 101522043

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 14 04 2020
accepted: 14 04 2020
pubmed: 23 5 2020
medline: 15 12 2020
entrez: 23 5 2020
Statut: ppublish

Résumé

Cardiovascular interventions have achieved a level of excellence, with many outstanding advanced techniques and results. The mission of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) is to further our understanding of cardiovascular intervention and establish its procedural safety. [1] The Japanese Percutaneous Coronary Intervention (J-PCI) registry was established and sponsored by CVIT, and aims to provide basic statistics on the performance of percutaneous coronary interventions (PCI) in Japan. Today, the database has grown to become one of the largest healthcare procedural database with more than 200,000 cases registered annually from approximately 900 institutions in Japan representing over 90% of all PCI hospitals in the nation. Importantly, case registrations in the J-PCI registry are essential for coronary interventionalist and educating hospital certification. The present manuscript aimed to summarize the history of the J-PCI registry and outline the definitions of various items.

Identifiants

pubmed: 32440831
doi: 10.1007/s12928-020-00669-z
pii: 10.1007/s12928-020-00669-z
pmc: PMC7295726
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-226

Références

Nihon Geka Gakkai Zasshi. 2014 Jan;115(1):22-8
pubmed: 24597333
Cardiovasc Interv Ther. 2010 Jan;25(1):1
pubmed: 24122425
JACC Cardiovasc Interv. 2017 May 8;10(9):918-927
pubmed: 28473114
Korean J Thorac Cardiovasc Surg. 2014 Oct;47(5):437-43
pubmed: 25346898
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):E1-E8
pubmed: 30467967
BMJ Open. 2019 May 22;9(5):e026683
pubmed: 31122979
Circulation. 2008 Sep 30;118(14 Suppl):S153-9
pubmed: 18824747
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 08;:
pubmed: 31593213
BMJ Qual Saf. 2020 Jul;29(7):560-568
pubmed: 31748402
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
Gen Thorac Cardiovasc Surg. 2019 Sep;67(9):731-735
pubmed: 31327137
Cardiovasc Diabetol. 2019 Nov 15;18(1):155
pubmed: 31730004
Am J Cardiol. 2017 Mar 15;119(6):872-880
pubmed: 28089413
J Am Heart Assoc. 2019 Mar 5;8(5):e011183
pubmed: 30791799
Am J Cardiol. 2017 Mar 15;119(6):826-831
pubmed: 28040190
Cardiovasc Interv Ther. 2019 Oct;34(4):297-304
pubmed: 30847655
Am J Cardiol. 2019 May 15;123(10):1595-1601
pubmed: 30846213
Ann Gastroenterol Surg. 2019 Aug 12;3(5):462-463
pubmed: 31549005
J Atheroscler Thromb. 2019 Nov 21;:
pubmed: 31748468
Am J Cardiol. 2020 Mar 1;125(5):720-726
pubmed: 31889525
J Am Heart Assoc. 2016 Nov 16;5(11):
pubmed: 27852588

Auteurs

Mitsuaki Sawano (M)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Kyohei Yamaji (K)

Division of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.

Shun Kohsaka (S)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Taku Inohara (T)

Division of Cardiology, Vancouver General Hospital, Vancouver, BC, Canada.

Yohei Numasawa (Y)

Department of Cardiology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan.

Hirohiko Ando (H)

Department of Cardiology, Aichi Medical University, Nagakute, Japan.

Osamu Iida (O)

Department of Cardiology, Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.

Toshiro Shinke (T)

Department of Cardiology, Showa University School of Medicine, Tokyo, Japan.

Hideki Ishii (H)

Department of Cardiology, Fujita Health University Bantane Hospital, Nagoya, Japan.

Tetsuya Amano (T)

Department of Cardiology, Aichi Medical University, Nagakute, Japan. amanotaha@yahoo.co.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH